The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan

OBJECTIVE: Hyponatremia is frequently observed in patients with decompensated liver cirrhosis and it is also related to a poor prognosis. The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic patients with ascites and increases the serum sodium (Na) level. In this study, we inv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Intern Med
Main Authors: Kogiso, Tomomi, Kobayashi, Mutsuki, Yamamoto, Kuniko, Ikarashi, Yuichi, Kodama, Kazuhisa, Taniai, Makiko, Torii, Nobuyuki, Hashimoto, Etsuko, Tokushige, Katsutoshi
Formato: Artigo
Idioma:Inglês
Publicado: The Japanese Society of Internal Medicine 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725852/
https://ncbi.nlm.nih.gov/pubmed/28943585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.9033-17
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares